Medical/Pharmaceuticals

A Visionary Breakthrough: VISTA Eye Specialist and EssilorLuxottica Join Forces to Combat Childhood Myopia in Malaysia

PETALING JAYA, Malaysia, April 25, 2025 /PRNewswire/ -- In a landmark move to safeguard the vision ofMalaysia's future generation, VISTA Eye Specialist ('VISTA'), the nation's trusted eye care brand, announced a strategic collaborationMemorandum of Understanding (MoU) with EssilorLuxottica, the ...

2025-04-25 08:00 2775

VivaVision Announces Positive Topline Results from Phase 2 Trial of VVN461 for Non-Infectious Anterior Uveitis

* VVN461, a dual JAK1/TYK2 inhibitor as a non-steroidal anti-inflammatory agent, has met primary endpoints, demonstrating non-inferior efficacy compared to the standard therapy, prednisolone acetate (PA) in treating NIAU * Clinically meaningful reductions in inflammation compared to baseline ...

2025-04-25 00:00 2663

Medit and Graphy Announce Strategic Partnership to Advance Digital Orthodontics

SEOUL, South Korea, April 24, 2025 /PRNewswire/ -- Medit, a global leader in digital dentistry solutions, and Graphy, a leading innovator in 3D printing dental materials, have officially announced a strategic partnership to accelerate advancements in the digital orthodontics market.

2025-04-25 00:00 3241

Primo's Taoyuan Facility Achieves PIC/S GMP Certification, Paving the Way for Global Expansion in Nuclear Medicine.

TAIPEI, April 24, 2025 /PRNewswire/ -- Primo Biotechnology Co., Ltd. ("Primo") proudly announces that its Taoyuan pharmaceutical facility has successfully passed inspection by Taiwan Food and Drug Administration (TFDA) and has been award dual certification for PIC/S GMP and GDP. This achievement ...

2025-04-24 23:00 2438

Mabwell to Present Clinical Data of 9MW2821 Combined with Toripalimab in Patients with UC in an Oral Presentation at 2025 ASCO

SHANGHAI, April 24, 2025 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with an entire industry chain, announced that thePhase Ib/II clinical study results of the novel Nectin-4-targeting ADC 9MW2821 combined with toripalimab in patients with locally advanced...

2025-04-24 20:00 2294

Sengkang General Hospital Introduces Siemens Healthineers Photon-Counting CT Scanner to Advance Diagnostic Capabilities

* New photon-counting CT scanner aims to enhance diagnostic imaging capabilities for SKH. * Advanced technology provides clearer images with lower radiation dose, improving diagnostic precision and patient safety. SINGAPORE, April 24, 2025 /PRNewswire/ --Sengkang General Hospital (SKH) offici...

2025-04-24 18:57 2766

Dizal to Showcase Data in Hematologic Malignancies and Lung Cancer at ASCO 2025

* DZD8586 study results in B-cell non-Hodgkin lymphomas (B-NHLs) were selected for oral and poster presentations. The analysis in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) after covalent or non-covalent BTK inhibitors and BTK degraders was selected for oral presentation ...

2025-04-24 18:38 2330

OMRON Healthcare Donates 4,000 Blood Pressure Monitors and Advances AFib Screening with AI-based Intellisense AFib Technology

- Intellisense AFib Technology Able to Detect Possible Atrial Fibrillation with Every Measurement; May17 Marks World Hypertension Day during May Measurement Month - KYOTO, Japan, April 24, 2025 /PRNewswire/ -- OMRON Healthcare Co., Ltd. (Head Office: Muko,Kyoto Prefecture; hereinafter referred t...

2025-04-24 16:00 2130

Ping An Health Reports 25.8% Year-on-Year Revenue Growth in Q1 2025, with Profitability Accelerating

Revenue and Profit Surge, Driven by "AI + Health Care" Value Empowerment SHANGHAI and HONG KONG, April 24, 2025 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited ("Ping An Good Doctor", "Ping An Health" or "the Company", Stock Code: 1833.HK) announced its first-quarter results for...

2025-04-24 15:30 3596

SWS Medical and Hemotek - Partners in Innovations at the 45th Philippine Society of Nephrology Annual Convention

MANILA, Philippines, April 24, 2025 /PRNewswire/ -- SWS Medical, a leading Chinese blood purification provider, is excited to participate in the 45th Philippine Society of Nephrology Annual Convention (April 24-26, 2025 Preferred Booth 1),the Philippines' largest nephrology academic event. In par...

2025-04-24 14:57 2704

Sun Pharma and Moebius Medical Announce Dual Publications on MM-II's Phase 2b Clinical Trial Results and Mechanism of Action in Osteoarthritis and Cartilage

- Durable pain relief from a single MM-II injection and its cartilage-protective effects in OA models featured in two peer-reviewed articles - - New data on MM-II to be presented this weekend at the OARSI 2025 World Conference on Osteoarthritis - - MM-II recently granted Fast Track Designation ...

2025-04-24 14:31 2254

Kelun-Biotech to Present Results of Six Clinical Studies at 2025 ASCO Annual Meeting

CHENGDU, China, April 24, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (6990.HK) announced that it will present results from six Kelun-led clinical studies at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, held inChicago from May 30 to June 3. Resu...

2025-04-24 13:17 2287

Antengene to Present Latest Results From Two Clinical Studies at ASCO 2025

SHANGHAI and HONG KONG, April 24, 2025 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for hem...

2025-04-24 10:26 2435

2025 Medtec Free Pre-Registration Kicks Off! Meet Over 1000 Chinese Local Enterprises

SHANGHAI, April 24, 2025 /PRNewswire/ -- The 2025 Medtec International Medical Device Design & Manufacturing Technology Exhibition (hereinafter referred to as 2025 Medtec) will be held at the Halls 1&2 of Shanghai World Expo Exhibition & Convention Center fromSeptember 24 to September 26. This ex...

2025-04-24 09:00 1237

Seven Oral Presentations: Innovent to Present Breakthrough Clinical Data of IBI363(PD-1/IL-2α-bias)and Other Novel Drug Candidates at the 2025 ASCO Annual Meeting

SAN FRANCISCO and SUZHOU,China, April 24, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune...

2025-04-24 07:00 3576

CGBIO Receives FDA IDE Approval for NOVOSIS PUTTY, Advancing Toward U.S. Market Entry

- The bone graft incorporating rhBMP-2 has received FDA IDE approval for a pivotal clinical trial in spinal fusion - Positioned for global expansion in $750M spinal bone graft market SEOUL, South Korea, April 23, 2025 /PRNewswire/ -- CGBIO(CEO Hyun Seung Yu), a leading Korean company specializing...

2025-04-24 00:00 2863

SimonMed Imaging Partners with Lunit to Deliver Best-in-Class AI for Breast Cancer Detection

A Major Leap Forward in Patient Health and the Future of Mammography PHOENIX, April 23, 2025 /PRNewswire/ -- SimonMed Imaging®, one of the largest and most advanced outpatient medical imaging providers inthe United States, is proud to announce their partnership with Lunit, a global leader in AI-d...

2025-04-24 00:00 2539

LakeShore Biopharma Announces the Official Launch of a Novel Packaging Solution for YSJA™ Rabies Vaccine (Vero Cell)

Revolutionizing Vaccination Safety with Needle-Free Reconstitution Technology BEIJING, April 23, 2025 /PRNewswire/ -- On April 18, 2025, LakeShore Biopharma Co., Ltd. (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company") successfully held the 2025 CSO ("Contract Sales Organization") Annual Meeti...

2025-04-23 21:35 2496

FIELD MEDICAL ANNOUNCES FIRST-IN-HUMAN DATA FOR FOCAL PFA IN SCAR-RELATED VT AT HEART RHYTHM 2025

Eight presentations, including late-breaking science, live cases, and a landmark symposium CARDIFF-BY-THE-SEA, Calif., April 23, 2025 /PRNewswire/ -- Field Medical Inc., a leader in cardiac pulsed field ablation (PFA) technology, announced today its FieldForce™ Ablation System will be featured i...

2025-04-23 20:33 2630

Tsingke Gene Leads a Delivery Revolution with "Calendar Day Delivery"

BEIJING, April 23, 2025 /PRNewswire/ -- In March 2025, Tsingke pioneered the industry's first full-range "Calendar Day Delivery" model, redefining standards for gene synthesis services through a comprehensive suite of offerings such asTsynth™Gene Synthesis

2025-04-23 17:18 1944
1 ... 9596979899100101 ... 645

Week's Top Stories